TODD BAZEMORE
Profile
First Name
: TODD
Middle Name
:
Last Name
: BAZEMORE
Related Companies
Titles
Company Name
Related People
DIRECTOR
AKIHISA AKAO, HOJABR ALIMI, RICHARD BATYCKY, CHRISTOPHER CABELL, ROBERT CLARKE, RICHARD CONLEY, WILLIAM DUKE, GREGORY FRENCH, STEVEN GILLIS, KURT GRAVES, SAMEER HARISH, DAVID HAVA, MICHAEL HIGGINS, MICHAEL J. HIGGINS, MARK IWICKI, PETER LUDLUM, DAVID MAKI, TERRANCE MCGUIRE, AMIT MUNSHI, AMIT D. MUNSHI, . OCULUS INNOVATIVE SCIENCES, INC., TEOFILO RAAD, JAMES ROACH, SCOTT ROCKLAGE, MATTHEW SHERMAN, MICHELLE S. SIEGERT, ANAND VARADAN
EXECUTIVE OFFICER
CHAIM BERGER, KEVIN BITTERMAN, MARK S. BLUMENKRANZ, KIM BRAZZELL, HONGMING CHEN, YONATAN COLMAN, PETER COUROSSI, MARJAN FARID, ANDREA FRANZ, BERNARD GILLY, GREG GRUNBERG, GREGORY GRUNBERG, JUSTIN HANES, MARK IWICKI, DARIUS KHARABI, ANDREW I. KOVEN, ANDREW L. KOVEN, ROBERT LANGER, DAVID LAZAR, CHARLES MCDERMOTT, AVI MINKOWITZ, C. DANIEL MYERS, ROBERT PAULL, GREGORY D. PERRY, GUILLAUME PFEFER, KEVIN POJASEK, HILLEL POSEN, BRENDAN PURDY, MARY REUMUTH, HOWARD B. ROSEN, RAJEEV SHAH, ROBERT TEPPER, ERIC L. TRACHTENBERG, KAREN WAGNER, CHEN YU
EXECUTIVE OFFICER
CHAIM BERGER, KEVIN BITTERMAN, MARK S. BLUMENKRANZ, KIM BRAZZELL, HONGMING CHEN, YONATAN COLMAN, PETER COUROSSI, MARJAN FARID, ANDREA FRANZ, BERNARD GILLY, GREG GRUNBERG, GREGORY GRUNBERG, JUSTIN HANES, MARK IWICKI, DARIUS KHARABI, ANDREW I. KOVEN, ANDREW L. KOVEN, ROBERT LANGER, DAVID LAZAR, CHARLES MCDERMOTT, AVI MINKOWITZ, C. DANIEL MYERS, ROBERT PAULL, GREGORY D. PERRY, GUILLAUME PFEFER, KEVIN POJASEK, HILLEL POSEN, BRENDAN PURDY, MARY REUMUTH, HOWARD B. ROSEN, RAJEEV SHAH, ROBERT TEPPER, ERIC L. TRACHTENBERG, KAREN WAGNER, CHEN YU
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-03-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-12-31
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-06-28
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-11-15
